Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Le Dung, Ha"'
Autor:
Matthew T. Wheeler, Le Dung Ha, Julia Hock, Victor F. Froelicher, David Hadley, Tamanna Singh
Publikováno v:
Clinical Journal of Sport Medicine. 31:388-391
OBJECTIVE Because the International left atrial enlargement electrocardiographic (ECG) screening criteria (ECG-LAE) for athletes are rarely fulfilled in young athletes, we compared it with evidence-based criteria from a recent clinical outcome study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::620a3382be539a9cbedce227a7d32bbd
https://doi.org/10.1097/jsm.0000000000000766
https://doi.org/10.1097/jsm.0000000000000766
Publikováno v:
Heart International, Vol 12, Iss 1, Pp 0-0 (2017)
IntroductionData are limited on the degree of mild troponin I elevation and clinical risk factors in predicting myocardial ischemia.MethodsHospitalized adult patients who underwent myocardial perfusion imaging (MPI) from 2015 to 2016 at Rochester Gen
Externí odkaz:
https://doaj.org/article/e15e06c34a034478a4bed8c88fe3a0d7
Autor:
Sorin J, Brener, Gregory J, Cunn, Pankil H, Desai, Mouzamjha, Faroqui, Le Dung, Ha, Garima, Handa, Issa, Kutkut, Adnan S, Raza, Terrence J, Sacchi
Publikováno v:
The Journal of invasive cardiology. 33(4)
To identify patients undergoing complex, high-risk indicated percutaneous coronary intervention (CHIP-PCI) and compare their outcomes with non-CHIP patients. We created a CHIP score to risk stratify these patients.Risk stratification of PCI patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2dad6cc8e2f24db809f1a01ab73fc7d7
https://pubmed.ncbi.nlm.nih.gov/33542159
https://pubmed.ncbi.nlm.nih.gov/33542159
Autor:
Le Dung Ha, Marwan Saad, Matthew J. Budoff, Atif Qasim, Oluwaseun Adeola, Amr F. Barakat, Amgad Mentias, Islam Y. Elgendy, Antoine Addoumieh, Ahmed Abuzaid, Ahmed N. Mahmoud, Hesham K. Abdelaziz, Akram Y. Elgendy, Ayman Elbadawi
Publikováno v:
Coronary artery disease. 32(4)
Coronary artery calcium (CAC) is an indicator of atherosclerosis, and the CAC score is a useful noninvasive assessment of coronary artery disease.To compare the risk of cardiovascular outcomes in patients with CAC0 versus CAC = 0 in asymptomatic and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bdd1a1e38601068b032fd7f45a470e2
https://pubmed.ncbi.nlm.nih.gov/33417339
https://pubmed.ncbi.nlm.nih.gov/33417339
Autor:
Susan S. Smyth, Remi Okwechime, Claude S. Elayi, Odunayo Olorunfemi, Gbolahan O. Ogunbayo, Deborah Akanya, Ayman Elbadawi, Maya Guglin, Ahmed Abdel-Latif, Le Dung Ha, Adrian W. Messerli, Yousef Darrat
Publikováno v:
Angiology. 70:317-324
Atrial fibrillation (AF) can present with non-ST-segment elevation myocardial infarction (NSTEMI). The incidence, characteristics, outcomes, and treatment of this subgroup of patients with AF remains poorly studied. Using data from the National Inpat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7efbb3379cdf9db873ae20f0a2b70b0
https://doi.org/10.1177/0003319718801087
https://doi.org/10.1177/0003319718801087
Autor:
Naoki Misumida, Adrian W. Messerli, Qamar Ahmad, Andrew R. Kolodziej, Le Dung Ha, Ahmed Abdel-Latif, Claude S. Elayi, Gbolahan O. Ogunbayo, Odunayo Olorunfemi, Ayman Elbadawi, Maya Guglin
Publikováno v:
Heart & Lung. 47:392-397
Introduction This study compared inpatient outcomes related to the use of these two devices among patients who developed cardiogenic shock not due to acute myocardial infarction or coronary revascularization. Methods We extracted admission-level reco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e72cd4ef43b3b663a95f6af23f417d11
https://doi.org/10.1016/j.hrtlng.2018.02.002
https://doi.org/10.1016/j.hrtlng.2018.02.002
Publikováno v:
Coronary Artery Disease. 28:670-674
BACKGROUND Although coronary artery bypass graft surgery (CABG) has been proven to have mortality and morbidity benefits in patients with non-ST elevation myocardial infarction and multivessel disease, the appropriate timing of this procedure remains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d8efc118b6b4353606d6fcf353a5ef6
https://doi.org/10.1097/mca.0000000000000537
https://doi.org/10.1097/mca.0000000000000537
Publikováno v:
American Journal of Case Reports. 2017, Vol. 18, p251-254. 4p.
Autor:
Karim Mahmoud, Michael Megaly, Le Dung Ha, Gbolahan O. Ogunbayo, Ahmed Abuzaid, Jeremiah P. Depta, Islam Y. Elgendy, Erfan Alotaki, Ayman Elbadawi, Basarat Baig, Marwan Saad
Publikováno v:
The American Journal of Cardiology. 120:1055-1061
The efficacy and safety of glycoprotein IIb/IIIa inhibitors via intracoronary (IC) route versus the intravenous (IV) route are not well known. We conducted this meta-analysis of randomized trials evaluating the role of IC versus IV glycoprotein IIb/I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffff011fa81ef689b1ec5b73f072c46e
https://doi.org/10.1016/j.amjcard.2017.06.040
https://doi.org/10.1016/j.amjcard.2017.06.040
Publikováno v:
The American Journal of Cardiology. 119:832-838
Ischemia/reperfusion injury adversely affects the final infarct size (IS) after primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). Few studies have evaluated the role of remote ischem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9692e26882cf4e8f8758e5772923e2fb
https://doi.org/10.1016/j.amjcard.2016.11.036
https://doi.org/10.1016/j.amjcard.2016.11.036